Skip to content
★ Sign in to follow
RS

Robert S. Brown

CEO
NxStage Medical, Inc.
Total declarations
149
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (57 ops.)
€11.4M

Latest filing published 04 Apr 2017 for NxStage Medical, Inc., €174k.

Filing timeline

BuySale
Robert S. Brown

Insider track record

Disclosed buys
0
Disclosed sells
57
Signal history

Robert S. Brown: trading record in brief

Robert S. Brown discloses dealings in NxStage Medical, Inc. to SEC (Form 4). The record holds 149 filings, for trades running from 3 March 2010 to 3 April 2017.

Sales make up the whole of the open-market record (57 sales, €11.4M). Outside the open market, there are 22 share grants and 70 option exercises. Since January 2017: no purchases and 18 sales on the market.

The record was last updated on 4 April 2017 with an option exercise (€174k) in NxStage Medical, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Robert S. Brown

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations147 total
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    185,667 USD22SEC
    11,917 shares@ US$15.582.7% of flowCommon StockSEC:0001246360-17-001558:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    382,960 USD41SEC
    14,397 shares@ US$26.605.6% of flowCommon StockSEC:0001246360-17-001558:1
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    333,200 USD22SEC
    20,000 shares@ US$16.664.9% of flowCommon StockSEC:0001246360-17-001251:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    555,000 USD41SEC
    20,000 shares@ US$27.758.2% of flowCommon StockSEC:0001246360-17-001251:1
  • ◆
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    129,830 USD22SEC
    4,586 shares@ US$28.311.9% of flowCommon StockSEC:0001246360-17-001214:1
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    178,984 USD40SEC
    6,390 shares@ US$28.012.6% of flowCommon StockSEC:0001246360-17-001214:2
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    0SEC
    9,747 shares0Common StockSEC:0001246360-17-001214:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    69,229 USD40SEC
    2,448 shares@ US$28.281.0% of flowCommon StockSEC:0001246360-17-000752:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    84,321 USD40SEC
    3,054 shares@ US$27.611.2% of flowCommon StockSEC:0001246360-17-000491:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    85,842 USD40SEC
    3,117 shares@ US$27.541.2% of flowCommon StockSEC:0001246360-17-000462:0
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    190,580 USD22SEC
    13,000 shares@ US$14.662.8% of flowCommon StockSEC:0001246360-17-000452:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    348,010 USD41SEC
    13,000 shares@ US$26.775.0% of flowCommon StockSEC:0001246360-17-000452:1
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    89,593 USD40SEC
    3,283 shares@ US$27.291.3% of flowCommon StockSEC:0001246360-17-000452:2
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    190,580 USD22SEC
    13,000 shares@ US$14.662.7% of flowCommon StockSEC:0001246360-17-000417:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    522,393 USD41SEC
    19,602 shares@ US$26.657.5% of flowCommon StockSEC:0001246360-17-000417:1
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    190,580 USD22SEC
    13,000 shares@ US$14.662.8% of flowCommon StockSEC:0001246360-17-000417:2
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    474,146 USD41SEC
    17,745 shares@ US$26.726.9% of flowCommon StockSEC:0001246360-17-000417:3
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    165,450 USD22SEC
    15,000 shares@ US$11.032.4% of flowCommon StockSEC:0001246360-17-000341:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    387,900 USD41SEC
    15,000 shares@ US$25.865.6% of flowCommon StockSEC:0001246360-17-000341:1
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    220,600 USD22SEC
    20,000 shares@ US$11.033.2% of flowCommon StockSEC:0001246360-17-000341:2
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    522,600 USD41SEC
    20,000 shares@ US$26.137.6% of flowCommon StockSEC:0001246360-17-000341:3
  • ◇
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    77,210 USD22SEC
    7,000 shares@ US$11.031.1% of flowCommon StockSEC:0001246360-17-000341:4
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    183,750 USD40SEC
    7,000 shares@ US$26.252.7% of flowCommon StockSEC:0001246360-17-000341:5
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    174,680 USD40SEC
    6,415 shares@ US$27.232.6% of flowCommon StockSEC:0001246360-17-000246:0
  • ▼
    President, NxStage Kidney CareExecutivesNxStage Medical, Inc.
    5,582 USD40SEC
    200 shares@ US$27.910.1% of flowCommon StockSEC:0001246360-17-000246:1

25 of 147 declarations